Indian drugmaker Dr Reddy’s gearing up for March debut of generic semaglutide Obeda, sources say
Audio By Carbonatix By Rishika Sadam MUMBAI, Feb 25 (Reuters) – Indian drugmaker Dr Reddy’s Laboratories is likely to launch its generic semaglutide injection in the country in March under the brand name Obeda, according to two people familiar with the …